Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP programmes and uptake news

Show

From To
Here's how to get onto England's PrEP trial

Will Nutland of Prepster explains.

Published
06 March 2019
From
Gay Star News
Councils in London may block additional PrEP places proposed for gay and bisexual men

NHS England announced today that whilst the PrEP Impact trial will double the number of places on the trial in clinics outside London, local authority commissioners in London are still considering what proportion of the proposed additional places they wish to accept. Fifty per cent of PrEP Impact Trial places are for London clinics.

Published
28 February 2019
From
National AIDS Trust
PrEP Impact Trial to be expanded

New places for the PrEP Impact Trial will now start to be released following agreement at the PrEP Oversight Board.

Published
28 February 2019
From
NHS England
Scotland's introduction of HIV drug PrEP 'puts England to shame'

Campaigners who want to see HIV PrEP (HIV Pre-Exposure Prophylaxis) made similarly available elsewhere in the UK say that Scotland’s initial success “puts England’s sluggish delivery to shame”.

Published
28 February 2019
From
The Guardian
Major shift in HIV war as Kenyans now top users of prevention pill

About 54,000 Kenyans are using the daily HIV prevention pill today up from 9,000 a year ago. This is the second highest use in the world after US, which has 197,000 users in a population of 325 million.

Published
27 February 2019
From
The Standard
Scotland: PrEP drug uptake 'exceeds predictions'

Almost 1,900 people have been prescribed a drug which dramatically reduces the chances of being infected with HIV, new figures have shown.

Published
27 February 2019
From
BBC
Implementation of HIV PrEP in Scotland: First Year Report

Scotland is one of the first countries worldwide to have successfully established a HIV PrEP (HIV Pre-Exposure Prophylaxis) service which is national, free at the point of delivery and, to date, generally accessible to most deemed at highest risk of acquiring HIV.

Published
27 February 2019
From
Health Protection Scotland
Men who have sex with men in China are unsure about PrEP

Gay men in China could benefit from more information around PrEP to increase uptake and curb new HIV infections in this group.

Published
24 February 2019
From
AVERT
Viet Nam announces nationwide rollout of PrEP

Dr Heather-Marie Schmidt, WHO/UNAIDS Regional PrEP Advisor for Asia and the Pacific, spoke to Associate Professor Phan Thi Thu Huong, Deputy Director General of the Viet Nam Authority of HIV/AIDS Control, about PrEP in Viet Nam.

Published
19 February 2019
From
World Health Organization
While The NHS Drags Its Heels On PrEP, This Is How Men Are Being Affected

Although NHS England increased places in the PrEP Impact Trial to 13,000 participants in summer and recently said it hopes to extend this to 26,000 before 2020, it is yet to confirm when these places will become available – or what will happen when the three-year trial is up. Around 40% of trial clinics across England are currently turning away gay and bisexual men due to oversubscription, according to the Terrence Higgins Trust. Six men who’ve failed to access PrEP have told HuffPost UK the experience has left them feeling “depressed”, “anxious” and “frustrated”.

Published
12 February 2019
From
Huffington Post

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.